Xenetic Biosciences
Stock Forecast, Prediction & Price Target
Xenetic Biosciences Financial Estimates
Xenetic Biosciences Revenue Estimates
Xenetic Biosciences EBITDA Estimates
Xenetic Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.16M N/A | $1.70M 47.06% | $2.53M 48.80% | Avg: $1.8M Low: $1.8M High: $1.8M avg. -29.13% | Avg: $2.3M Low: $2.3M High: $2.3M avg. 27.77% | Avg: $2.5M Low: $2.5M High: $2.5M avg. 8.69% | Avg: $9.7M Low: $9.7M High: $9.7M avg. 288% |
Net Income
% change YoY
| $-5.54M N/A | $-6.38M -15.18% | $-4.13M 35.26% | Avg: $-1.11M Low: $-1.11M High: $-1.11M avg. 73.01% | Avg: $-1.05M Low: $-1.05M High: $-1.05M avg. 5.47% | Avg: $-1.23M Low: $-1.23M High: $-1.23M avg. -17.39% | Avg: $-1.23M Low: $-1.23M High: $-1.23M avg. 0% |
EBITDA
% change YoY
| $-5.71M N/A | $-6.69M -17.15% | $-4.51M 32.50% | Avg: $-1.08M Low: $-1.08M High: $-1.08M avg. 76.08% | Avg: $-1.38M Low: $-1.38M High: $-1.38M avg. -27.77% | Avg: $-1.5M Low: $-1.5M High: $-1.5M avg. -8.69% | Avg: $-5.82M Low: $-5.82M High: $-5.82M avg. -288% |
EPS
% change YoY
| -$5.39 N/A | -$4.49 16.69% | -$2.71 39.64% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. 73.06% | Avg: -$0.69 Low: -$0.69 High: -$0.69 avg. 5.47% | Avg: -$0.81 Low: -$0.81 High: -$0.81 avg. -17.39% | Avg: -$0.81 Low: -$0.81 High: -$0.81 avg. 0% |
Operating Expenses
% change YoY
| $6.90M N/A | $8.42M 21.96% | $7.05M -16.25% | Avg: $105.04M Low: $105.04M High: $105.04M avg. 1388.72% | Avg: $134.21M Low: $134.21M High: $134.21M avg. 27.77% | Avg: $145.88M Low: $145.88M High: $145.88M avg. 8.69% | Avg: $566.04M Low: $566.04M High: $566.04M avg. 288.00% |
FAQ
What is Xenetic Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.27% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -1.11M, average is -1.11M and high is -1.11M.
What is Xenetic Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 73.83% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $1.8M, average is $1.8M and high is $1.8M.
What is Xenetic Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.28% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.73, average is -$0.73 and high is $-0.73.